Earnings
ATRA
13.90
+1.46%
0.20
Currencies: USD
Items
Cash and Cash Equivalents
Short-term Investments
Short-term Securities
Accounts Receivable
Notes Receivable
Interest Receivable
Other Receivables
Prepayments
Inventories
Holding Assets for Sale
Unamortized Expenditures
Other Current Assets
Total Current Assets
Fixed Assets Net
Long-term Receivables
Long-term Investments
Deferred Tax Asset
Goodwill
Intangible Assets
Long-term Deferred Expenses
Other Non-current Assets
Total Non-current Assets
Total Assets
Short/Current Long Term Debt
Accounts Payable
Notes Payable
Taxes and Dues Payable
Salary Payable
Financing Expenses Payable
Other Payable
Advance Receipt
Accrued Expenses
Deferred Income
Holding Liabilities For Sale
Financial Derivative Liabilities
Other Current Liabilities
Total Current Liabilities
Long-term Debt
Long-term Payables
Long-term Deferred Income
Long-term Deferred Tax Liabilities
Other Non-current Liabilities
Total Non-current Liabilities
Total Liabilities
Common Stocks
Additional Paid-in Capital
Retained Earnings
Treasury Shares
Other Equity Instruments
Minority Interest
Equities Attributable to Parent Company
Total Equities
Total Liabilities and Equities
FY 2020-12-31
200.40M
300.25M
--
1.25M
--
--
0.00
--
--
--
21.17M
194.00K
523.27M
62.82M
--
--
--
--
--
--
2.03M
64.85M
588.12M
--
7.12M
0.00
--
--
--
--
--
42.07M
--
--
--
33.45M
82.90M
149.00K
--
--
--
42.73M
42.88M
125.78M
8000.00
1.59B
-1.12B
--
--
--
462.34M
462.34M
588.12M
FY 2019-12-31
74.32M
184.79M
--
--
--
--
0.00
--
--
--
13.69M
194.00K
272.99M
68.18M
--
--
--
--
--
--
1.77M
69.95M
342.94M
--
7.96M
0.00
--
--
--
--
--
28.51M
--
--
--
--
36.74M
244.00K
--
--
--
15.17M
15.42M
52.16M
6000.00
1.11B
-817.96M
--
--
--
290.78M
290.78M
342.94M
FY 2018-12-31
60.70M
248.93M
--
--
--
--
0.00
--
--
--
11.66M
194.00K
321.49M
68.58M
--
--
--
--
--
--
1.77M
70.35M
391.84M
--
3.72M
0.00
--
--
--
--
--
29.85M
--
--
--
6.41M
39.98M
0.00
--
--
--
13.00M
13.00M
52.98M
5000.00
866.54M
-527.35M
--
--
--
338.86M
338.86M
391.84M
FY 2017-12-31
79.22M
86.87M
--
--
--
--
0.00
--
--
--
5.90M
194.00K
172.19M
44.13M
--
--
--
--
--
--
1.46M
45.59M
217.78M
--
14.71M
0.00
--
--
--
--
--
9.67M
--
--
--
3.27M
27.65M
0.00
--
--
--
12.27M
12.27M
39.91M
3000.00
474.66M
-296.65M
--
--
--
177.86M
177.86M
217.78M
FY 2016-12-31
47.97M
207.71M
--
--
--
--
0.00
--
--
--
4.68M
194.00K
260.55M
3.26M
--
--
--
--
--
--
102.00K
3.36M
263.91M
--
2.78M
0.00
--
--
--
--
--
6.15M
--
--
--
744.00K
9.68M
0.00
--
--
--
503.00K
503.00K
10.18M
3000.00
431.07M
-177.16M
--
--
--
253.74M
253.74M
263.91M

FY: Financial Year. It represents annual report.

Q: Quarter Report. Q1、Q2、Q3、Q4 represent three-month periodic financial reports.

Check out ATRA latest quarterly and annual financial reports. There are also historical financial reports for you to reference. You can analyze Atara Biotherapeutics Inc recent business situations by check its income statements, balance sheets, cash flow statements and other tables. This information may help you make smarter investment decisions.